肿瘤诊治与预后专栏

嗜铬细胞瘤与副神经节瘤围手术期全程管理差异及血流动力学稳定性研究

  • 李钰婷 ,
  • 殷巧丽 ,
  • 张玉秀 ,
  • 李楠 ,
  • 孔昊
展开
  • 1.北京大学第一医院,麻醉科,(北京 100034 )
    2.北京大学第一医院宁夏妇女儿童医院麻醉科 (宁夏 银川 750002 )
    3.北京大学第一医院,重症医学科,(北京 100034 )

收稿日期: 2026-01-03

  网络出版日期: 2026-04-29

基金资助

宁夏自然科学基金项目(2024AAC03735);中央高水平医院临床科研业务费资助(北京大学第一医院院内交叉研究专项)(2023IR22)

Comparative study on perioperative comprehensive management and hemodynamic stability in pheochromocytoma and paraganglioma

  • Yuting LI ,
  • Qiaoli YIN ,
  • Yuxiu ZHANG ,
  • Nan LI ,
  • Hao KONG
Expand
  • 1.Department of Anesthesiology,Peking University First Hospital,Beijing 100034,Beijing,Chin
    2Department of Anesthesiology,Peking University First Hospital Ningxia Women and Children's Hospital,Yinchuan 750002,Ningxia,Chin
    a3Department of Critical Care Medicine,Peking University First Hospital,Beijing 100034,Beijing,China

Received date: 2026-01-03

  Online published: 2026-04-29

摘要

目的 对比嗜铬细胞瘤(pheochromocytoma,PCC)与腹部副神经节瘤(paraganglioma,PGL)患者围麻醉手术期的临床特征及血流动力学稳定性差异,为制定个体化围术期管理策略提供循证依据。 方法 回顾性收集2005年1月至2024年12月在北京大学第一医院接受手术治疗的692例患者临床资料,其中PCC组535例,腹部PGL组157例。采用标准化数据收集流程,通过多重填补法处理缺失数据,对关键结局指标进行多因素回归分析以控制混杂因素。比较两组术前基线资料、术前准备情况、术中关键指标及术后恢复结局。 结果 与PCC组相比,PGL组肿瘤最大径更大(P < 0.001),术前最高收缩压(P = 0.019)和舒张压(P = 0.023)更高,血浆去甲肾上腺素水平更高(P = 0.044),血浆甲氧基肾上腺素水平更低(P = 0.006),α受体阻滞剂使用时长更长(P = 0.015),且更倾向于使用非选择性α受体阻滞剂。术中PGL组开放手术占比更高(P < 0.001),手术时长更长(P < 0.001),术中改良血流动力学不稳定评分更高(P < 0.001),出血量更多(P < 0.001)。术后PGL组入住ICU比例、机械通气使用率更高,ICU停留时间、机械通气时间及术后住院时间更长(P < 0.05),两组术后主要并发症发生率差异无统计学意义(P = 0.343)。多因素回归分析显示,肿瘤类型PGL是术中血流动力学不稳定的独立危险因素。 结论 与PCC相比,PGL患者围术期呈现术中血流动力学稳定性更差、出血量更多、术后恢复时间更长等特征。

本文引用格式

李钰婷 , 殷巧丽 , 张玉秀 , 李楠 , 孔昊 . 嗜铬细胞瘤与副神经节瘤围手术期全程管理差异及血流动力学稳定性研究[J]. 实用医学杂志, 2026 , 42(9) : 1561 -1569 . DOI: 10.3969/j.issn.1006-5725.2026.09.010

Abstract

Objective To compare perioperative clinical characteristics and hemodynamic stability between patients with pheochromocytoma (PCC) and abdominal paraganglioma (PGL), and to provide evidence-based recommendations for individualized perioperative management. Methods This retrospective study analyzed clinical data from 692 patients who underwent surgical resection at Peking University First Hospital between January 2005 and December 2023. Patients were stratified into the PCC group (n = 535) and the abdominal PGL group (n = 157). Data were collected using a standardized protocol; missing values were addressed via multiple imputation. Multivariate regression analysis was employed to control for confounding factors. Comparisons were made regarding preoperative baseline characteristics, preparation protocols, intraoperative metrics, and postoperative recovery outcomes. Results Compared to the PCC group, patients with PGL presented with larger tumor diameters (P < 0.001), higher preoperative systolic (P = 0.019) and diastolic blood pressure (P = 0.023), elevated plasma norepinephrine levels (P = 0.044), and reduced plasma metanephrine levels (P = 0.006). PGL patients required a longer duration of α-blockade (P = 0.015) and showed a higher utilization rate of non-selective α-blockers. Intraoperatively, the PGL group underwent open surgery more frequently (P < 0.001), experienced longer operative times (P < 0.001), exhibited higher modified hemodynamic instability scores (P < 0.001), and sustained greater blood loss (P < 0.001). Postoperatively, the PGL group demonstrated higher rates of ICU admission and mechanical ventilation, along with prolonged ICU stays, ventilation duration, and hospitalization (all P < 0.05). No significant difference was observed in the incidence of major complications (P = 0.343). Multivariate analysis identified PGL as an independent risk factor for intraoperative hemodynamic instability. Conclusion PGL patients face greater perioperative challenges than PCC patients, characterized by inferior hemodynamic stability, increased blood loss, and delayed recovery.

参考文献

[1] 中华医学会内分泌学分会. 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识 (2020 版)[J]. 中华内分泌代谢杂志,2020, 36 (9):737-750. doi:10.3760/cma.j.cn311282-20200629-00482 .
[2] LENDERS J W, DUH Q Y, EISENHOFER G, et al. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2014, 99 (6):1915-1942. doi:10.1210/jc.2014-1498 .
[3] AL-HARTHY M, AL-HARTHY S, AL-OTIESCHAN A, et al. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas [J]. Endocr Pract, 2009, 15 (3):194-202. doi:10.4158/EP.15.3.194 .
[4] 刘鹭,田杰,吴恺,等. 血浆游离型甲氧基肾上腺素类物质检测正常的嗜铬细胞瘤和副神经节瘤的临床特点 [J]. 北京大学学报 (医学版), 2020, 52 (4):614-620. doi:10.19723/j.issn.1671-167X.2020.04.003 .
[5] 徐千越.嗜铬细胞瘤及副神经节瘤的临床及病理研究 [D]. 南京:南京大学,2016.
[6] EZZAT ABDEL-AZIZ T, PRETE F, CONWAY G, et al. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes [J]. J Surg Oncol, 2015, 112 (5):486-491. doi:10.1002/jso.24030 .
[7] 周亚琼,严鹏,张华敏,等.腹部副神经节瘤的临床特征及长期预后分析 [J]. 实用医学杂志,2021, 37 (21):2743-2747. doi:10.3969/j.issn.1006-5725.2021.21.008 .
[8] NEUMANN H P H, YOUNG W F Jr, ENG C. Pheochromocytoma and Paraganglioma [J]. N Engl J Med, 2019, 381 (6):552-565. doi:10.1056/NEJMra1806651 .
[9] BUITENWERF E, OSINGA T E, TIMMERS H J L M, et al. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial [J]. J Clin Endocrinol Metab, 2020, 105 (7):2381-2391. doi:10.1210/clinem/dgz188 .
[10] BUITENWERF E, BOEKEL M F, VAN DER VELDE M I, et al. The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability [J]. Eur J Anaesthesiol, 2019, 36 (4):290-297. doi:10.1097/EJA.0000000000001084 .
[11] KONG H, ZHANG Y X, YIN Q L, et al. Efficacy and Safety of Preemptive Magnesium Sulfate Infusion during Pheochromocytoma and Paraganglioma Resection: A Randomized, Double-blind, Placebo-controlled Trial [J]. Anesthesiology, 2025, 144(2):301-313. doi:10.1097/ALN.0000000000005778 .
[12] GROUZMANN E, TSCHOPP O, TRIPONEZ F, et al. Catecholamine metabolism in paraganglioma and pheochromocytoma: Similar tumors in different sites?[J]. PLoS One, 2015, 10 (5):e0125426. doi:10.1371/journal.pone.0125426 .
[13] VAN DER ZEE P A, DE BOER A. Pheochromocytoma: A review on preoperative treatment with phenoxybenzamine or doxazosin [J]. Neth J Med, 2014, 72 (4):190-201.
[14] KONG H, LI N, YANG X C, et al. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching [J]. Anesth Analg, 2021, 132 (1):140-149. doi:10.1213/ANE.0000000000005070 .
[15] 《嗜铬细胞瘤围术期管理专家共识》专家编写组. 嗜铬细胞瘤围术期管理专家共识(2025版)[J]. 中华内分泌外科杂志(中英文), 2025, 19 (6):793-800. doi:10.3760/cma.j.cn115807-20251102-00307 .
[16] MA W, MAO Y, ZHUO R, et al. Surgical outcomes of a randomized controlled trial compared robotic versus laparoscopic adrenalectomy for pheochromocytoma [J]. Eur J Surg Oncol, 2020, 46 (10 Pt A):1843-1847. doi:10.1016/j.ejso.2020.04.001 .
[17] LI N, KONG H, LI S L, et al. Combined epidural-general anesthesia was associated with lower risk of postoperative complications in patients undergoing open abdominal surgery for pheochromocytoma: A retrospective cohort study [J]. PLoS One, 2018, 13 (2):e0192924. doi:10.1371/journal.pone.0192924 .
[18] CHANG R Y, LANG B H, WONG K P, et al. High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma/paraganglioma removal [J]. World J Surg, 2014, 38 (9):2317-2323. doi:10.1007/s00268-014-2597-9 .
[19] MA L, SHEN L, ZHANG X, et al. Predictors of hemodynamic instability in patients with pheochromocytoma and paraganglioma [J]. J Surg Oncol, 2020, 122 (4):803-808. doi:10.1002/jso.26079 .
[20] DE FILPO G, PARENTI G, SPARANO C, et al. Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: A retrospective study [J]. World J Surg Oncol, 2023, 21 (1):192. doi:10.1186/s12957-023-03072-z .
[21] NIEDERLE M B, FLEISCHMANN E, KABON B, et al. The determination of real fluid requirements in laparoscopic resection of pheochromocytoma using minimally invasive hemodynamic monitoring: A prospectively designed trial [J]. Surg Endosc, 2020, 34 (1):368-376. doi:10.1007/s00464-019-06777-z .
[22] GROEBEN H, WALZ M K, NOTTEBAUM B J, et al. International multicentre review of perioperative management and outcome for catecholamine-producing tumours [J]. Br J Surg, 2020, 107 (2):e170-e178. doi:10.1002/bjs.11378 .
[23] 廖远键,姚菁菁,左明顺,等. 转移性嗜铬细胞瘤和副神经节瘤遗传学研究进展 [J].实用医学杂志, 2023, 39 (23):3137-3142. doi:10.3969/j.issn.1006-5725.2023.23.020 .
[24] LI N, KONG H, LI S L, et al. Combined epidural-general anesthesia was associated with lower risk of postoperative complications in patients undergoing open abdominal surgery for pheochromocytoma: A retrospective cohort study [J]. PLoS One, 2018, 13 (2):e0192924. doi:10.1371/journal.pone.0192924 .
[25] EFREMOV S, ALEXEEV M, KULESHOV O, et al. Prognostic Model for Vasopressor Requirement After Retroperitoneal Adrenalectomy for Pheochromocytoma: A Retrospective Study [J]. J Cardiothorac Vasc Anesth, 2023, 37 (7):1230-1235. doi:10.1053/j.jvca.2023.02.043 .
[26] ZHANG L, CHEN D, PANG Y, et al. Surgical treatment of large pheochromocytoma (>6 cm): A 10-year single-center experience [J]. Asian J Urol, 2022, 9 (3):294-300. doi:10.1016/j.ajur.2022.04.004 .
文章导航

/